|
1
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dong Y, Skelley AM, Merdek KD, Sprott KM,
Jiang C, Pierceall WE, Lin J, Stocum M, Carney WP and Smirnov DA:
Microfluidics and circulating tumor cells. J Mol Diagn. 15:149–157.
2013. View Article : Google Scholar
|
|
3
|
Li P, Stratton ZS, Dao M, Ritz J and Huang
TJ: Probing circulating tumor cells in microfluidics. Lab Chip.
13:602–609. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Friedlander TW, Premasekharan G and Paris
PL: Looking back, to the future of circulating tumor cells.
Pharmacol Ther. 142:271–280. 2014. View Article : Google Scholar
|
|
5
|
Broersen LH, van Pelt GW, Tollenaar RA and
Mesker WE: Clinical application of circulating tumor cells in
breast cancer. Cell Oncol (Dordr). 37:9–15. 2014. View Article : Google Scholar
|
|
6
|
Mitchell MJ and King MR: Computational and
experimental models of cancer cell response to fluid shear stress.
Front Oncol. 3:442013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barnes JM, Nauseef JT and Henry MD:
Resistance to fluid shear stress is a conserved biophysical
property of malignant cells. PloS One. 7:e509732012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aktas B, Tewes M, Fehm T, Hauch S, Kimmig
R and Kasimir-Bauer S: Stem cell and epithelial-mesenchymal
transition markers are frequently overexpressed in circulating
tumor cells of metastatic breast cancer patients. Breast Cancer
Res. 11:R462009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ip CK, Li SS, Tang MY, Sy SK, Ren Y, Shum
HC and Wong AS: Stemness and chemoresistance in epithelial ovarian
carcinoma cells under shear stress. Sci Rep. 6:267882016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nguyen LV, Vanner R, Dirks P and Eaves CJ:
Cancer stem cells: An evolving concept. Nat Rev Cancer. 12:133–143.
2012.PubMed/NCBI
|
|
11
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar
|
|
14
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liao M-J, Zhang CC, Zhou B, Zimonjic DB,
Mani SA, Kaba M, Gifford A, Reinhardt F, Popescu NC, Guo W, et al:
Enrichment of a population of mammary gland cells that form
mammospheres and have in vivo repopulating activity. Cancer Res.
67:8131–8138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
18
|
Haley EM, Tilson SG, Triantafillu UL,
Magrath JW and Kim Y: Acidic pH with coordinated reduction of basic
fibroblast growth factor maintains the glioblastoma stem cell-like
phenotype in vitro. J Biosci Bioeng. Jan 4–2017.Epub ahead of
print. View Article : Google Scholar
|
|
19
|
Mallini P, Lennard T, Kirby J and Meeson
A: Epithelial-to-mesenchymal transition: What is the impact on
breast cancer stem cells and drug resistance. Cancer Treat Rev.
40:341–348. 2014. View Article : Google Scholar
|
|
20
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van Roy F: Beyond E-cadherin: Roles of
other cadherin super-family members in cancer. Nat Rev Cancer.
14:121–134. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schnell U, Cirulli V and Giepmans BN:
EpCAM: Structure and function in health and disease. Biochim
Biophys Acta. 1828:1989–2001. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan X, Curtin J, Xiong Y, Liu G,
Waschsmann-Hogiu S, Farkas DL, Black KL and Yu JS: Isolation of
cancer stem cells from adult glioblastoma multiforme. Oncogene.
23:9392–9400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bos PD, Nguyen DX and Massagué J: Modeling
metastasis in the mouse. Curr Opin Pharmacol. 10:571–577. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saxena M and Christofori G: Rebuilding
cancer metastasis in the mouse. Mol Oncol. 7:283–296. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tang KD, Holzapfel BM, Liu J, Lee TK, Ma
S, Jovanovic L, An J, Russell PJ, Clements JA, Hutmacher DW, et al:
Tie-2 regulates the stemness and metastatic properties of prostate
cancer cells. Oncotarget. 7:2572–2584. 2016.
|
|
28
|
Lee HJ and Koh GY: Shear stress activates
Tie2 receptor tyrosine kinase in human endothelial cells. Biochem
Biophys Res Commun. 304:399–404. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Green DL and Karpatkin S: Effect of cancer
on platelets. Coagulation in Cancer. Kwaan CH and Green D:
Springer; Boston, MA: pp. 17–30. 2009, View Article : Google Scholar
|
|
30
|
Gay LJ and Felding-Habermann B:
Contribution of platelets to tumour metastasis. Nat Rev Cancer.
11:123–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mitchell MJ, Denais C, Chan MF, Wang Z,
Lammerding J and King MR: Lamin A/C deficiency reduces circulating
tumor cell resistance to fluid shear stress. Am J Physiol Cell
Physiol. 309:C736–C746. 2015.PubMed/NCBI
|
|
32
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Reymond N, d'Água BB and Ridley AJ:
Crossing the endothelial barrier during metastasis. Nat Rev Cancer.
13:858–870. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nieman MT, Prudoff RS, Johnson KR and
Wheelock MJ: N-cadherin promotes motility in human breast cancer
cells regardless of their E-cadherin expression. J Cell Biol.
147:631–644. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ricardo S, Vieira AF, Gerhard R, Leitão D,
Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F and Paredes
J: Breast cancer stem cell markers CD44, CD24 and ALDH1: Expression
distribution within intrinsic molecular subtype. J Clin Pathol.
64:937–946. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mani SA, Guo W, Liao M-J, Eaton EN,
Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et
al: The epithelial-mesenchymal transition generates cells with
properties of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu
Y, Martin-Trevino R, Shang L, McDermott SP, Landis MD, et al:
Breast cancer stem cells transition between epithelial and
mesenchymal states reflective of their normal counterparts. Stem
Cell Rep. 2:78–91. 2013. View Article : Google Scholar
|
|
38
|
Sanpaolo P, Barbieri V and Genovesi D:
Prognostic value of breast cancer subtypes on breast cancer
specific survival, distant metastases and local relapse rates in
conservatively managed early stage breast cancer: A retrospective
clinical study. Eur J Surg Oncol. 37:876–882. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Paquet ER and Hallett MT: Absolute
assignment of breast cancer intrinsic molecular subtype. J Natl
Cancer Inst. 107:dju3572015. View Article : Google Scholar
|
|
40
|
Holliday DL and Speirs V: Choosing the
right cell line for breast cancer research. Breast Cancer Res.
13:2152011. View Article : Google Scholar : PubMed/NCBI
|
